Please enter the email address you used to register, then we will send you a link to choose a new password
MHUA: 121% | Meihua International Announced That Its NT-2000 Surgical Path Analysis System Successfully Supported The World's Second 5G Remote Robot-assisted Lobectomy
MGNX: -28% | MacroGenics shares are trading lower. The company announced a presentation of clinical data from the TAMARACK Phase 2 study of vobramitamab duocarmazine at the upcoming European Society for Medical Oncology Congress 2024. Multiple analysts on Wednesday downgraded the stock.
VST: 17% | Vistra shares are trading higher after the company announced that the Nuclear Regulatory Commission has approved its request to extend the operation of Comanche Peak Nuclear Power Plant through 2053.
Posted In: MGNX MHUA VST